Device hirstory revord review result: affected product: 70104.6577 be-015703112#hls module advanced adult packaging lot: 70130424 (dms#2762657) production lot: 70129590 (dms#(b)(4)) the documentation for the packaging lot and production lot was reviewed on 2020-06-22.There were no references found, which are indicating a nonconformance of the product in question.A similar case was already investigate under complaint#310782: as stated in the investigation report of ot#310782 clots could be found inside the oxygenator.An increasing delta-p throughout the course of the extracorporeal circulation procedures, including ecmo, is an expected and known side effect.Whereas a rapid increase cannot be regarded as expected, the delta-p can also increase by none-coagulation relating factors, e.G.By ¿pseudofibrine deposits¿ which can be caused or promoted by drugs, such as propofol or by nutrition of the patient.According to the risk assessment (hls set advanced 5.0 / hls set advanced 7.0, dms # (b)(4), v23) following causes could lead to coagulation: -de-airing luer lock connection too loose -air remains in or enters the circuit -hemostasis -air or blood remains in luer lock access port -too low anticoagulation -too low at level, effect of heparin is too limited -protamine sulfate enters the hls set -administration of substitution of congealable substance such as plateles -(consumption) coagulopathy -thrombozytopenia thus the failure could be confirmed.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿ s trending program and additional investigations or corrections will be implemented in case of adverse trending.
|